MedPath

Asthma in the Delta Region of Arkansas (ADRA): Prevalence and Morbidity

Completed
Conditions
Asthma
Registration Number
NCT00589719
Lead Sponsor
Arkansas Children's Hospital Research Institute
Brief Summary

The purpose of the study is to conduct a cross-sectional study to examine asthma prevalence and morbidity in a predominately minority, low-income population in rural Arkansas.

Detailed Description

Asthma is the leading chronic disease of childhood in the United States and an important public health concern in Arkansas. Arkansas, a predominately rural state, has one of the leading mortality rates in the nation for African Americans. The specific aims of the study will examine asthma prevalence in children age 4-17 years old in public schools in Eudora and Marvell Arkansas. The study will also examine asthma morbidity among identified asthmatics by characterizing activity limitation, days missed from school, daytime and nocturnal symptoms, healthcare utilization and medication use. The specific aims of the current study will provide novel data on an understudied population of asthmatics and will test our working hypotheses that pediatric asthma prevalence in the Delta region of Arkansas is higher than national estimates; and asthma diagnosis is related to significant morbidity among rural asthmatics.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
964
Inclusion Criteria
  • Children aged 4-17 years, enrolled in the public schools in Eudora and Marvell Arkansas.
Exclusion Criteria
  • Children aged 18 or older enrolled in the public schools in Eudora and Marvell Arkansas were excluded.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The findings suggest that asthma diagnosis and active symptoms are prevalent among this predominately minority and low-income rural population in the Arkansas region of the Mississippi Delta.One year
Secondary Outcome Measures
NameTimeMethod
High rates of inadequately controlled asthma are evidenced by activity limitation, medication use and increased healthcare utilization.One year

Trial Locations

Locations (1)

Arkansas Children's Hospital Research Institute

🇺🇸

Little Rock, Arkansas, United States

© Copyright 2025. All Rights Reserved by MedPath